PMC9357113

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

The vast majority of patients with diabetes agreed that medication adherence would control their diabetes (88.7%) and improve their quality of life (91.7%), though only 60-70% believed medications wou

Effect: improvement; 88.7% agreed meds control diabetes; 91.7% agreed meds improve QoL

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage

A majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri

Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage